公开(公告)号：US10967055B2

公开(公告)日：2021-04-06

申请号：US16113924

申请日：2018-08-27

Applicant: The Texas A&M University System

Inventor： James E. Samuel ,  Erin J. Van Schaik ,  Anthony E. Gregory

IPC: A61K39/00 ,  A61K39/02 ,  A61K39/39

Abstract: A vaccine includes at least one bacterial antigen capable of producing an immune response in a host when the vaccine is administered at a dose that is sufficient for preventing or treating Q fever in the host. The vaccine composition confers immunity against Q fever without the reactogenic side effects observed in prior art vaccines.

公开(公告)号：US20190083598A1

公开(公告)日：2019-03-21

申请号：US16113924

申请日：2018-08-27

Applicant: The Texas A&M University System

Inventor： James E. Samuel ,  Erin J. Van Schaik ,  Anthony E. Gregory

IPC: A61K39/02 ,  A61K39/39

Abstract: A vaccine includes at least one bacterial antigen capable of producing an immune response in a host when the vaccine is administered at a dose that is sufficient for preventing or treating Q fever in the host. The vaccine composition confers immunity against Q fever without the reactogenic side effects observed in prior art vaccines.